LIFE SCIENCES
Deep life sciences capital-raising expertise
Driven by the vagaries of research, regulatory oversight, and the rigor and cost of clinical development, life sciences is arguably one of the most dynamic and complex of all industries, with multiple factors affecting capital requirements and funding needs. At-the-market offerings such as Brinson Patrick’s DOCS® (Dynamic Offering of Common Stock) ATM financing facility enable life sciences companies ultimate flexibility to raise smaller amounts of cash, and to start and stop that flow as R&D or other initiatives demand. |
|